Ultrasound imaging is a widely accepted tool for guiding interventional instruments such as needles to targets such as blood vessels or organs in the human body. In order to successfully guide, for example, a needle to a blood vessel using ultrasound imaging, the needle is monitored in real-time both immediately before and after a percutaneous puncture in order to enable a clinician to determine the distance and the orientation of the needle to the blood vessel and ensure successful access thereto. However, through inadvertent movement of an ultrasound probe during the ultrasound imaging, the clinician can lose both the blood vessel and the needle, which can be difficult and time consuming to find again. In addition, it is often easier toc monitor the distance and orientation of the needle immediately before the percutaneous puncture with a needle plane including the needle perpendicular to an image plane of the ultrasound probe. And it is often easier to monitor the distance and orientation of the needle immediately after the percutaneous puncture with the needle plane parallel to the image plane. As with inadvertently moving the ultrasound probe, the clinician can lose both the blood vessel and the needle when adjusting the image plane before and after the percutaneous puncture, which can be difficult and time consuming to find again. What is needed are ultrasound imaging systems and methods thereof that can dynamically adjust the image plane to facilitate guiding interventional instruments to targets in at least the human body.
Doppler ultrasound is a noninvasive approach to estimating the blood flow through your blood vessels by bouncing high-frequency sound waves (ultrasound) off circulating red blood cells. A doppler ultrasound can estimate how fast blood flows by measuring the rate of change in its pitch (frequency). Doppler ultrasound may be performed as an alternative to more-invasive procedures, such as angiography, which involves injecting dye into the blood vessels so that they show up clearly on X-ray images. Doppler ultrasound may help diagnose many conditions, including blood clots, poorly functioning valves in your leg veins, which can cause blood or other fluids to pool in your legs (venous insufficiency), heart valve defects and congenital heart disease, a blocked artery (arterial occlusion), decreased blood circulation into your legs (peripheral artery disease), bulging arteries (aneurysms), and narrowing of an artery, such as in your neck (carotid artery stenosis). Doppler ultrasound may also detect a direction of blood flow within a blood vessel.
Disclosed herein is an ultrasound imaging system including an ultrasound probe including an array of ultrasonic transducers and an orientation system, wherein the ultrasonic transducers are configured to emit generated ultrasound signals into a patient, receive reflected ultrasound signals from the patient, and convert the reflected ultrasound signals into corresponding electrical signals of the ultrasound signals for processing into ultrasound images, and wherein the orientation system is configured to obtain orientation information of the ultrasound probe, a console configured to communicate with the ultrasound probe, the console including one or more processors and a non-transitory computer-readable medium having stored thereon logic, when executed by the one or more processors, causes operations including: obtaining the orientation information; performing an identification process on the ultrasound signals to identify an anatomical target (e.g., a target vessel); determining, based on the orientation information, a direction of movement required by the ultrasound probe to place the ultrasound probe at a predetermined position relative to the anatomical target (e.g., to center the ultrasound probe over the anatomical target); and initiating provision of feedback to a user of the ultrasound probe indicating the direction of movement required by the ultrasound probe to center the ultrasound probe over the anatomical target.
In some embodiments, the orientation information indicates positioning of the ultrasound probe on a Cartesian coordinate system relative to a skin surface of the patient. In some embodiments, the ultrasound probe includes an inertial measurement unit configured to obtain the orientation information. In some embodiments, the ultrasound probe includes an optical fiber having one or more of core fibers, wherein each of the one or more core 106s includes a plurality of sensors distributed along a longitudinal length of a corresponding core fiber and each sensor of the plurality of sensors is configured to (i) reflect a light signal of a different spectral width based on received incident light, and (ii) change a characteristic of the reflected light signal for use in determining a physical state of the optical fiber.
In some embodiments, the operations further include: providing a broadband incident light signal to the optical fiber, receiving a reflected light signal of the broadband incident light, wherein the reflected light signal is reflected from red blood cells within the patient body, and processing the reflected light signal to determine the orientation information. In some embodiments, the identification process includes applying a trained machine learning model configured to detect anatomical features within the ultrasound images and provide a bounding box around the anatomical target. In some embodiments, the provision of the feedback includes providing haptic feedback from a first side of the ultrasound probe, where the first side corresponds to the direction of movement required by the ultrasound probe to center the ultrasound probe over the anatomical target. In some embodiments, the system includes a needle including a second orientation system configured to obtain needle orientation information, and wherein the operations further include: determining, based on the needle orientation information, an orientation of the needle relative to the ultrasound probe, determining a trajectory of the needle, and generating a display screen illustrating the trajectory of the needle.
Also disclosed herein is a method of providing the ultrasound imaging system discussed above and providing instructions to cause performance of the operations also discussed above. Additionally, disclosed herein is a non-transitory, computer-readable medium having logic stored thereon that, when executed by a processor causes performance of the operations discussed above.
These and other features of the concepts provided herein will become more apparent to those of skill in the art in view of the accompanying drawings and following description, which describe particular embodiments of such concepts in greater detail.
Embodiments of the disclosure are illustrated by way of example and not by way of limitation in the figures of the accompanying drawings, in which like references indicate similar elements and in which:
Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.
Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
With respect to “proximal,” a “proximal portion” or a “proximal-end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near a clinician when the catheter is used on a patient. Likewise, a “proximal length” of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient. A “proximal end” of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient. The proximal portion, the proximal-end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal-end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal-end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.
With respect to “distal,” a “distal portion” or a “distal-end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near or in a patient when the catheter is used on the patient. Likewise, a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient. A “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient. The distal portion, the distal-end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal-end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal-end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.
As set forth above, ultrasound imaging systems and methods thereof are needed that can dynamically adjust the image plane to facilitate guiding interventional instruments to targets in at least the human body. Disclosed herein are dynamically adjusting ultrasound imaging systems and methods thereof.
Referring now to
The console 102 houses a variety of components of the ultrasound imaging system 100, and it is appreciated the console 102 can take any of a variety of forms. A processor 116 and memory 118 such as random-access memory (“RAM”) or non-volatile memory (e.g., electrically erasable programmable read-only memory (“EEPROM”)) are included in the console 102 for controlling functions of the ultrasound imaging system 100. The processor may execute various logic operations or algorithms during operation of the ultrasound imaging system 100 in accordance with executable logic (“instructions”) 120 stored in the memory 118 for execution by the processor 116. For example, the console 102 is configured to instantiate by way of the logic 120 one or more processes for dynamically adjusting a distance of activated ultrasonic transducers 148 from a predefined target (e.g., blood vessel) or area, an orientation of the activated ultrasonic transducers 148 to the predefined target or area, or both the distance and the orientation of the activated ultrasonic transducers 148 with respect to the predefined target or area, as well as process electrical signals from the ultrasound probe 106 into ultrasound images. Dynamically adjusting the activated ultrasonic transducers 148 uses ultrasound imaging data, magnetic-field data, shape-sensing data, or a combination thereof received by the console 102 for activating certain ultrasonic transducers of a 2-D array of the ultrasonic transducers 148 or moving those already activated in a linear array of the ultrasonic transducers 148. A digital controller/analog interface 122 is also included with the console 102 and is in communication with both the processor 116 and other system components to govern interfacing between the ultrasound probe 106 and other system components set forth herein.
The ultrasound imaging system 100 further includes ports 124 for connection with additional components such as optional components 126 including a printer, storage media, keyboard, etc. The ports 124 can be universal serial bus (“USB”) ports, though other types of ports can be used for this connection or any other connections shown or described herein. A power connection 128 is included with the console 102 to enable operable connection to an external power supply 130. An internal power supply 132 (e.g., a battery) can also be employed either with or exclusive of the external power supply 130. Power management circuitry 134 is included with the digital controller/analog interface 122 of the console 102 to regulate power use and distribution.
The display screen 104 is integrated into the console 102 to provide a GUI and display information for a clinician during such as one-or-more ultrasound images of the target or the patient P attained by the ultrasound probe 106. In addition, the ultrasound imaging system 100 enables the distance and orientation of a magnetized medical device such as the needle 112 to be superimposed in real-time atop an ultrasound image of the target, thus enabling a clinician to accurately guide the magnetized medical device to the intended target. Notwithstanding the foregoing, the display screen 104 can alternatively be separate from the console 102 and communicatively coupled thereto. A console button interface 136 and control buttons 110 (see
The ultrasound probe 106 is employed in connection with ultrasound-based visualization of a target such as a blood vessel (see
Optionally, a stand-alone optical interrogator 154 can be communicatively coupled to the console 102 by way of one of the ports 124. Alternatively, the console 102 can include an integrated optical interrogator integrated into the console 102. Such an optical interrogator is configured to emit input optical signals into a companion optical-fiber stylet 156 for shape sensing with the ultrasound imaging system 100, which optical-fiber stylet 156, in turn, is configured to be inserted into a lumen of a medical device such as the needle 112 and convey the input optical signals from the optical interrogator 154 to a number of FBG sensors along a length of the optical-fiber stylet 156. The optical interrogator 154 is also configured to receive reflected optical signals conveyed by the optical-fiber stylet 156 reflected from the number of FBG sensors, the reflected optical signals indicative of a shape of the optical-fiber stylet 156. The optical interrogator 154 is also configured to convert the reflected optical signals into corresponding electrical signals for processing by the console 102 into distance and orientation information with respect to the target for dynamically adjusting a distance of the activated ultrasonic transducers 148, an orientation of the activated ultrasonic transducers 148, or both the distance and the orientation of the activated ultrasonic transducers 148 with respect to the target or the medical device when it is brought into proximity of the target.
For example, the distance and orientation of the activated ultrasonic transducers 148 can be adjusted with respect to a blood vessel as the target. Indeed, an image plane can be established by the activated ultrasonic transducers 148 being perpendicular or parallel to the blood vessel in accordance with an orientation of the blood vessel. As used herein, the term “orientation information” may refer to the positioning of the probe 106 (or other medical instrument) in three dimensions relative to a fixed axis. In some embodiments, the fixed axis may refer to a perpendicular axis extending distally from a surface of a patient P (e.g., which may be representative of the Z-axis of a Cartesian coordinate system). Thus, orientation information of the probe 106 provides a geometric view of an angle of the ultrasound probe relative to the skin surface of patient P. Additionally, orientation information may provide an indication as to whether the ultrasound probe 106 is being held in a transverse or longitudinal orientation relative to a target vessel of the patient P.
Also as seen in
Though configured here as magnetic sensors, it is appreciated that the magnetic sensors 150 can be sensors of other types and configurations. Also, though they are described herein as included with the ultrasound probe 106, the magnetic sensors 150 of the magnetic-sensor array 146 can be included in a component separate from the ultrasound probe 106 such as a sleeve into which the ultrasound probe 106 is inserted or even a separate handheld device. The magnetic sensors 150 can be disposed in an annular configuration about the probe head 114 of the ultrasound probe 106, though it is appreciated that the magnetic sensors 150 can be arranged in other configurations, such as in an arched, planar, or semi-circular arrangement.
Each magnetic sensor of the magnetic sensors 150 includes three orthogonal sensor coils for enabling detection of a magnetic field in three spatial dimensions. Such 3-dimensional (“3-D”) magnetic sensors can be purchased, for example, from Honeywell Sensing and Control of Morristown, NJ. Further, the magnetic sensors 150 are configured as Hall-effect sensors, though other types of magnetic sensors could be employed. Further, instead of 3-D sensors, a plurality of 1-dimensional (“1-D”) magnetic sensors can be included and arranged as desired to achieve 1-, 2-, or 3-D detection capability.
As shown in
It is appreciated that a medical device of a magnetizable material enables the medical device (e.g., the needle 112) to be magnetized by a magnetizer, if not already magnetized, and tracked by the ultrasound imaging system 100 when the magnetized medical device is brought into proximity of the magnetic sensors 150 of the magnetic-sensor array 146 or inserted into the body of the patient P during an ultrasound-based medical procedure. Such magnetic-based tracking of the magnetized medical device assists the clinician in placing a distal tip thereof in a desired location, such as in a lumen of a blood vessel, by superimposing a simulated needle image representing the real-time distance and orientation of the needle 112 over an ultrasound image of the body of the patient P being accessed by the magnetized medical device. Such a medical device can be stainless steel such as SS 304 stainless steel; however, other suitable needle materials that are capable of being magnetized can be employed. So configured, the needle 112 or the like can produce a magnetic field or create a magnetic disturbance in a magnetic field detectable as magnetic signals by the magnetic-sensor array 146 of the ultrasound probe 106 so as to enable the distance and orientation of the magnetized medical device to be tracked by the ultrasound imaging system 100 for dynamically adjusting the distance of the activated ultrasonic transducers 148, an orientation of the activated ultrasonic transducers 148, or both the distance and the orientation of the activated ultrasonic transducers 148 with respect to the magnetized medical device. In some embodiments, the needle 112 can be tracked using the teachings of one or more patents of U.S. Pat. Nos. 5,775,322; 5,879,297; 6,129,668; 6,216,028; and 6,263,230, each of which is incorporated by reference in its entirety into this application.
In some embodiments, the distance and orientation information determined by the ultrasound imaging system 100, together with an entire length of the magnetized medical device, as known by or input into the ultrasound imaging system 100, enables the ultrasound imaging system 100 to accurately determine the distance and orientation of the entire length of the magnetized medical device, including a distal tip thereof, with respect to the magnetic-sensor array 146. This, in turn, enables the ultrasound imaging system 100 to superimpose an image of the needle 112 on an ultrasound image produced by the ultrasound beam 152 of the ultrasound probe 106 on the display screen 104. For example, the ultrasound image depicted on the display screen 104 can include depiction of the surface of the skin of the patient P and a subcutaneous blood vessel thereunder to be accessed by the needle 112, as well as a depiction of the magnetized medical device as detected by the ultrasound imaging system 100 and its orientation to the vessel. The ultrasound image corresponds to an image acquired by the ultrasound beam 152 of the ultrasound probe 106. It should be appreciated that only a portion of an entire length of the magnetized medical device is magnetized and, thus, tracked by the ultrasound imaging system 100.
During operation of the ultrasound imaging system 100, the probe head 114 of the ultrasound probe 106 is placed against skin of the patient P. An ultrasound beam 152 is produced so as to ultrasonically image a portion of a target such as a blood vessel beneath a surface of the skin of the patient P. (See
The pre-scan image 306 may be obtained at first time that is prior to preparing the patient P and the surrounding area for sterilization, where the pre-scan image 306 may be stored in the memory 118 of the console 102. The intended purpose of obtaining the pre-scan image 306 is to allow a clinician to obtain an image of the target vessel 302 using the ultrasound probe 106 without any constraints that may be imposed in order to maintain a sterile environment. As will be discussed below, the pre-scan image may then be used as a reference image to compare to the live scan image taken in a sterile field thereby allowing the clinician to confirm proper placement and orientation of the ultrasound probe 106.
In some embodiments, following operations to obtain, capture, and optionally to store, the pre-scan image, vessel identification logic 200 may be executed by the processor 116 causing performance of operations to identify a visual representation of the target vessel 302, such as the target vessel image 308 of
The vessel identification logic 200 may be configured, upon execution by the processor 116, to cause performance of operations including computerized, automated analysis of the pre-scan image 306 to identify the target vessel image 308 through machine learning operations (e.g., application of a trained machine learning model). For instance, computerized, automated analysis may include operations comprising object recognition such as object detection methods, where the vessel identification logic 200 parses the pre-scan image 306 to locate a presence of one or more objects (e.g., the target vessel 302) with a bounding box and classify (label) the object within the bounding box. In order to perform such operations, the vessel identification logic 200 may include a machine learning model trained through supervised machine learning using a labeled data set. For example, a labeled data set may include ultrasound images that were previously captured (“historical data”) that has also been labeled, e.g., by another trained machine learning model and/or by a subject matter expert. The machine learning model is then trained on the labeled historical data so that upon completion of the training, the machine learning model may detect objects within a new image (e.g., the pre-scan image 306 and a live scan image discussed below with respect to
The live scan image 406 may be obtained at second time that is subsequent to creating a sterilized area 402 around an insertion site on the patient P (or generally an area on the patient P. The live scan image 406 may also be stored in the memory 118 of the console 102. As noted above, systems and methods disclosed herein may include obtaining a pre-scan image 306 with the intended purpose of allowing a clinician to use the pre-scan image 306 as a reference image to compare to the live scan image 406 (which is taken in a sterile field) thereby allowing the clinician to confirm proper placement and orientation of the ultrasound probe 106 during the live scan process, which may correspond to insertion of a medical device such as the needle 112.
In some embodiments, following operations to obtain, capture, and optionally to store, the live scan image 406, the vessel identification logic 200 may be executed by the processor 116 causing performance of operations to identify a visual representation of the target vessel 302, such as the target vessel image 308, within the live scan image 406 and/or detect other features of the live scan image 406. Other features detected may include those anatomical features typically visualized in an ultrasound image such as blood vessels, bones, muscles, tendons, ligaments, nerves, joints, etc.
Referring now to
Referring to
Referring to
In some embodiments, the needle may also include a multi-core optical fiber 612 that extends the length of the needle 606 from either the console 102 or the probe 106. In such embodiments, the orientation of the needle 606 may be determined based on a shape sensing of the multi-core optical fiber 612 extending through a tether to the probe 106 (optional multi-core optical fiber 612′) or through a tether to the console 102 (optional multi-core optical fiber 612″). From the orientation of the probe 106 and the needle 606, a rendering of imaging captured by the probe 106, the target site 608, and the needle trajectory 610 may be generated and displayed on the display 104. Further, in addition to such information, knowledge of the human anatomy enables generation of a three-dimensional graphic for display on the display 104 (e.g., similar to the theoretical illustration of
As will be described below with respect to
Referring to
Referring to
For instance, the console may render an AR display screen 802 on the display 104. The AR display screen 802 may include certain visualizations as overlays on the ultrasound image obtained by the ultrasound probe 106. For example, the AR display screen 802 may include overlays that highlight certain anatomical features detected within the ultrasound image (e.g., vessels). In some embodiments, the target vessel may be distinguished visually from all detected anatomical features (e.g., the target vessel appears in a particular color, appears within a bounding box, etc.). Additional AR data that may be displayed includes directional indicators (e.g., “R”/“L” or “Right”/“Left”) that assist the clinician in properly characterizing a mirror coordination of the ultrasound probe 106, when applicable. Further, a center line may be overlaid on the ultrasound image as well as an arrow that instructs the clinician as to a direction to move the ultrasound probe 106 in order to center the ultrasound probe 106 over a target vessel, which places the target vessel in the center of the ultrasound image displayed on the display 104. The disclosure is also intended to disclose positioning of the ultrasound probe 106 that are alternative to the center a target vessel (or anatomical target, e.g., an organ, a vessel blockage, a chamber within a heart or position within an organ, etc.). For instance, it may be advantageous to place the ultrasound probe at a particular distance from the center of the target vessel in order to allow a needle to properly access an insertion site.
Additionally, the system 800 includes an AR device 804 that provides secondary AR data as an alternative to the AR display screen 802. The AR device 804 provides a second option (e.g., modality) for viewing AR data, while the first and secondary AR data may the same or substantially the same. As illustrated in
Referring now to
Referring to
Referring to
Referring to
Referring to
In the embodiment of
The above position and orientation information determined by the system 100, together with the length of the canula 1022 and position of the magnetic element 1024 with respect to the distal needle tip as known by or input into the system, enable the system 100 to accurately determine the location and orientation of the entire length of the needle 1020 with respect to the sensor array 1000. Optionally, the distance between the magnetic element 1024 and the distal needle tip is known by or input into the system 100. This in turn enables the system 100 to superimpose an image of the needle 1020 on to an image produced by the ultrasound beam 1006 of the probe 106.
Referring now to
Specifically,
Further details are given here regarding use of the system 100 in guiding a needle or other medical device in connection with ultrasonic imaging of a targeted internal body portion (“target”) of a patient, according to one embodiment. With the magnetic element-equipped needle 1020 positioned a suitable distance (e.g., two or more feet) away from the ultrasound probe 106 including the sensor array 1000, the probe is employed to ultrasonically image, for depiction on the display 104 of the system 100, the target within the patient that the needle is intended to intersect via percutaneous insertion. Following a calibration of the system 100 and obtaining or determining a total length of the needle 1020, and/or position of the magnetic element with respect to the distal needle tip such as by user input, automatic detection, or in another suitable manner, the needle 1020 is then brought into the range of the sensors 1002 of the sensor array 1000 of the probe 106. Each of the sensors 1002 detects the magnetic field strength associated with the magnetic element 1024 of the needle 1020, which data is forwarded to the processor 116. As the sensors 1002 detect the magnetic field, algorithms are performed by the processor 116 to calculate a magnetic field strength of the magnetic element 1024 of the needle 1020 at predicted points in space in relationship to the probe. The processor 116 then compares the actual magnetic field strength data detected by the sensors 1002 to the calculated field strength values (detail of this process is further described by the U.S. patents identified above). This process can be iteratively performed until the calculated value for a predicted point matches the measured data. Once this match occurs, the magnetic element 1024 has been positionally located in three-dimensional space. Using the magnetic field strength data as detected by the sensors 1002, the pitch and yaw (i.e., orientation) of the magnetic element 1024 can also be determined. Together with the known length of the needle 1020 and the position of the distal tip of the needle with respect to the magnetic element, this enables an accurate representation of the position and orientation of the needle can be made by the system 100 and depicted as a virtual model, i.e., the needle image 1034, on the display 104. Note that the predicted and actual detected values must match within a predetermined tolerance or confidence level in one embodiment for the system 100 to enable needle depiction to occur. Further detail as to the guidance of a needle toward a vessel within the body of a patient as discussed with respect to
Referring to
At stage 1206, a position of the medical component with respect to the targeted internal body portion is determined in at least two spatial dimensions via sensing of the detectable characteristic. As described above, such determination is made in the present embodiment by the processor 116 of the console 1120. At stage 1208, an image representing the position of the medical component is combined with the image of the targeted internal body portion for depiction on a display. At stage 1210, directional feedback is provided to the clinician directing movement (or confirming location) of an ultrasound probe utilized in capturing the image of the internal body portion. The directional feedback may be any as discussed above. Stage 1212 shows that stages 1204-1208 can be iteratively repeated to depict advancement or other movement of the medical component with respect to the imaged target, such as percutaneous insertion of the needle 1020 toward the vessel 1008 (
While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.
Number | Name | Date | Kind |
---|---|---|---|
5148809 | Biegeleisen-Knight et al. | Sep 1992 | A |
5181513 | Touboul et al. | Jan 1993 | A |
5325293 | Dorne | Jun 1994 | A |
5441052 | Miyajima | Aug 1995 | A |
5549554 | Miraki | Aug 1996 | A |
5573529 | Haak et al. | Nov 1996 | A |
5775322 | Silverstein et al. | Jul 1998 | A |
5879297 | Haynor et al. | Mar 1999 | A |
5908387 | LeFree et al. | Jun 1999 | A |
5967984 | Chu et al. | Oct 1999 | A |
5970119 | Hofmann | Oct 1999 | A |
6004270 | Urbano et al. | Dec 1999 | A |
6019724 | Gronningsaeter et al. | Feb 2000 | A |
6068599 | Saito et al. | May 2000 | A |
6074367 | Hubbell | Jun 2000 | A |
6129668 | Haynor et al. | Oct 2000 | A |
6132379 | Patacsil et al. | Oct 2000 | A |
6216028 | Haynor et al. | Apr 2001 | B1 |
6233476 | Strommer et al. | May 2001 | B1 |
6245018 | Lee | Jun 2001 | B1 |
6263230 | Haynor et al. | Jul 2001 | B1 |
6375615 | Flaherty et al. | Apr 2002 | B1 |
6436043 | Bonnefous | Aug 2002 | B2 |
6498942 | Esenaliev et al. | Dec 2002 | B1 |
6503205 | Manor et al. | Jan 2003 | B2 |
6508769 | Bonnefous | Jan 2003 | B2 |
6511458 | Milo et al. | Jan 2003 | B2 |
6524249 | Moehring et al. | Feb 2003 | B2 |
6543642 | Milliorn | Apr 2003 | B1 |
6554771 | Buil et al. | Apr 2003 | B1 |
6592520 | Peszynski et al. | Jul 2003 | B1 |
6592565 | Twardowski | Jul 2003 | B2 |
6601705 | Molina et al. | Aug 2003 | B2 |
6612992 | Hossack et al. | Sep 2003 | B1 |
6613002 | Clark et al. | Sep 2003 | B1 |
6623431 | Sakuma et al. | Sep 2003 | B1 |
6641538 | Nakaya et al. | Nov 2003 | B2 |
6647135 | Bonnefous | Nov 2003 | B2 |
6687386 | Ito et al. | Feb 2004 | B1 |
6749569 | Pellegretti | Jun 2004 | B1 |
6754608 | Svanerudh et al. | Jun 2004 | B2 |
6755789 | Stringer et al. | Jun 2004 | B2 |
6840379 | Franks-Farah et al. | Jan 2005 | B2 |
6857196 | Dalrymple | Feb 2005 | B2 |
6979294 | Selzer et al. | Dec 2005 | B1 |
7074187 | Selzer et al. | Jul 2006 | B2 |
7244234 | Ridley et al. | Jul 2007 | B2 |
7359554 | Klingensmith et al. | Apr 2008 | B2 |
7534209 | Abend et al. | May 2009 | B2 |
7599730 | Hunter et al. | Oct 2009 | B2 |
7637870 | Flaherty et al. | Dec 2009 | B2 |
7681579 | Schwartz | Mar 2010 | B2 |
7691061 | Hirota | Apr 2010 | B2 |
7699779 | Sasaki et al. | Apr 2010 | B2 |
7720520 | Willis | May 2010 | B2 |
7727153 | Fritz et al. | Jun 2010 | B2 |
7734326 | Pedain et al. | Jun 2010 | B2 |
7831449 | Ying et al. | Nov 2010 | B2 |
7905837 | Suzuki | Mar 2011 | B2 |
7925327 | Weese | Apr 2011 | B2 |
7927278 | Selzer et al. | Apr 2011 | B2 |
8014848 | Birkenbach et al. | Sep 2011 | B2 |
8050523 | Younge et al. | Nov 2011 | B2 |
8060181 | Rodriguez Ponce et al. | Nov 2011 | B2 |
8068581 | Boese et al. | Nov 2011 | B2 |
8075488 | Burton | Dec 2011 | B2 |
8090427 | Eck et al. | Jan 2012 | B2 |
8105239 | Specht | Jan 2012 | B2 |
8172754 | Watanabe et al. | May 2012 | B2 |
8175368 | Sathyanarayana | May 2012 | B2 |
8200313 | Rambod et al. | Jun 2012 | B1 |
8211023 | Swan et al. | Jul 2012 | B2 |
8228347 | Beasley et al. | Jul 2012 | B2 |
8298147 | Huennekens et al. | Oct 2012 | B2 |
8303505 | Webler et al. | Nov 2012 | B2 |
8323202 | Roschak et al. | Dec 2012 | B2 |
8328727 | Miele et al. | Dec 2012 | B2 |
8388541 | Messerly et al. | Mar 2013 | B2 |
8409103 | Grunwald et al. | Apr 2013 | B2 |
8449465 | Nair et al. | May 2013 | B2 |
8553954 | Saikia | Oct 2013 | B2 |
8556815 | Pelissier et al. | Oct 2013 | B2 |
8585600 | Liu et al. | Nov 2013 | B2 |
8622913 | Dentinger et al. | Jan 2014 | B2 |
8706457 | Hart et al. | Apr 2014 | B2 |
8727988 | Flaherty et al. | May 2014 | B2 |
8734357 | Taylor | May 2014 | B2 |
8744211 | Owen | Jun 2014 | B2 |
8754865 | Merritt et al. | Jun 2014 | B2 |
8764663 | Smok et al. | Jul 2014 | B2 |
8781194 | Malek et al. | Jul 2014 | B2 |
8781555 | Burnside et al. | Jul 2014 | B2 |
8790263 | Randall et al. | Jul 2014 | B2 |
8849382 | Cox et al. | Sep 2014 | B2 |
8939908 | Suzuki et al. | Jan 2015 | B2 |
8961420 | Zhang | Feb 2015 | B2 |
9022940 | Meier | May 2015 | B2 |
9138290 | Hadjicostis | Sep 2015 | B2 |
9155517 | Dunbar et al. | Oct 2015 | B2 |
9204858 | Pelissier et al. | Dec 2015 | B2 |
9220477 | Urabe et al. | Dec 2015 | B2 |
9257220 | Nicholls et al. | Feb 2016 | B2 |
9295447 | Shah | Mar 2016 | B2 |
9320493 | Visveshwara | Apr 2016 | B2 |
9357980 | Toji et al. | Jun 2016 | B2 |
9364171 | Harris et al. | Jun 2016 | B2 |
9427207 | Sheldon et al. | Aug 2016 | B2 |
9445780 | Hossack et al. | Sep 2016 | B2 |
9456766 | Cox et al. | Oct 2016 | B2 |
9456804 | Tamada | Oct 2016 | B2 |
9459087 | Dunbar et al. | Oct 2016 | B2 |
9468413 | Hall et al. | Oct 2016 | B2 |
9492097 | Wilkes et al. | Nov 2016 | B2 |
9521961 | Silverstein et al. | Dec 2016 | B2 |
9554716 | Burnside et al. | Jan 2017 | B2 |
9582876 | Specht | Feb 2017 | B2 |
9597008 | Henkel et al. | Mar 2017 | B2 |
9610061 | Ebbini et al. | Apr 2017 | B2 |
9636031 | Cox | May 2017 | B2 |
9649037 | Lowe et al. | May 2017 | B2 |
9649048 | Cox et al. | May 2017 | B2 |
9702969 | Hope Simpson et al. | Jul 2017 | B2 |
9715757 | Ng et al. | Jul 2017 | B2 |
9717415 | Cohen et al. | Aug 2017 | B2 |
9731066 | Liu et al. | Aug 2017 | B2 |
9814433 | Benishti et al. | Nov 2017 | B2 |
9814531 | Yagi et al. | Nov 2017 | B2 |
9861337 | Patwardhan et al. | Jan 2018 | B2 |
9895138 | Sasaki | Feb 2018 | B2 |
9913605 | Harris et al. | Mar 2018 | B2 |
9949720 | Southard et al. | Apr 2018 | B2 |
10043272 | Forzoni et al. | Aug 2018 | B2 |
10380919 | Savitsky et al. | Aug 2019 | B2 |
10380920 | Savitsky et al. | Aug 2019 | B2 |
10424225 | Nataneli et al. | Sep 2019 | B2 |
10434278 | Dunbar et al. | Oct 2019 | B2 |
10449330 | Newman et al. | Oct 2019 | B2 |
10524691 | Newman et al. | Jan 2020 | B2 |
10674935 | Henkel et al. | Jun 2020 | B2 |
10751509 | Misener | Aug 2020 | B2 |
10758155 | Henkel et al. | Sep 2020 | B2 |
10765343 | Henkel et al. | Sep 2020 | B2 |
10896628 | Savitsky et al. | Jan 2021 | B2 |
11062624 | Savitsky et al. | Jul 2021 | B2 |
11120709 | Savitsky et al. | Sep 2021 | B2 |
11311269 | Dunbar et al. | Apr 2022 | B2 |
11315439 | Savitsky et al. | Apr 2022 | B2 |
11600201 | Savitsky et al. | Mar 2023 | B1 |
20020038088 | Imran et al. | Mar 2002 | A1 |
20020148277 | Umeda | Oct 2002 | A1 |
20030047126 | Tomaschko | Mar 2003 | A1 |
20030060714 | Henderson et al. | Mar 2003 | A1 |
20030073900 | Senarith et al. | Apr 2003 | A1 |
20030093001 | Martikainen | May 2003 | A1 |
20030106825 | Molina et al. | Jun 2003 | A1 |
20030120154 | Sauer et al. | Jun 2003 | A1 |
20040055925 | Franks-Farah et al. | Mar 2004 | A1 |
20050000975 | Carco et al. | Jan 2005 | A1 |
20050049504 | Lo et al. | Mar 2005 | A1 |
20050165299 | Kressy et al. | Jul 2005 | A1 |
20050251030 | Azar et al. | Nov 2005 | A1 |
20050267365 | Sokulin et al. | Dec 2005 | A1 |
20060013523 | Childlers et al. | Jan 2006 | A1 |
20060015039 | Cassidy et al. | Jan 2006 | A1 |
20060020204 | Serra et al. | Jan 2006 | A1 |
20060079781 | Germond-Rouet et al. | Apr 2006 | A1 |
20060184029 | Haim et al. | Aug 2006 | A1 |
20060210130 | Germond-Rouet et al. | Sep 2006 | A1 |
20070043341 | Anderson et al. | Feb 2007 | A1 |
20070049822 | Bunce et al. | Mar 2007 | A1 |
20070073155 | Park et al. | Mar 2007 | A1 |
20070199848 | Ellswood et al. | Aug 2007 | A1 |
20070239120 | Brock et al. | Oct 2007 | A1 |
20070249911 | Simon | Oct 2007 | A1 |
20080021322 | Stone et al. | Jan 2008 | A1 |
20080033293 | Beasley et al. | Feb 2008 | A1 |
20080033759 | Finlay | Feb 2008 | A1 |
20080051657 | Rold | Feb 2008 | A1 |
20080146915 | McMorrow | Jun 2008 | A1 |
20080177186 | Slater et al. | Jul 2008 | A1 |
20080221425 | Olson et al. | Sep 2008 | A1 |
20080294037 | Richter | Nov 2008 | A1 |
20080300491 | Bonde et al. | Dec 2008 | A1 |
20090012399 | Sunagawa et al. | Jan 2009 | A1 |
20090143672 | Harms et al. | Jun 2009 | A1 |
20090143684 | Cermak et al. | Jun 2009 | A1 |
20090156926 | Messerly et al. | Jun 2009 | A1 |
20090306509 | Pedersen et al. | Dec 2009 | A1 |
20100020926 | Boese et al. | Jan 2010 | A1 |
20100106015 | Norris | Apr 2010 | A1 |
20100179428 | Pedersen et al. | Jul 2010 | A1 |
20100211026 | Sheetz et al. | Aug 2010 | A2 |
20100277305 | Garner et al. | Nov 2010 | A1 |
20100286515 | Gravenstein et al. | Nov 2010 | A1 |
20100312121 | Guan | Dec 2010 | A1 |
20110002518 | Ziv-Ari et al. | Jan 2011 | A1 |
20110071404 | Schmitt et al. | Mar 2011 | A1 |
20110295108 | Cox et al. | Dec 2011 | A1 |
20110313293 | Lindekugel et al. | Dec 2011 | A1 |
20120179038 | Meurer et al. | Jul 2012 | A1 |
20120197132 | O'Connor | Aug 2012 | A1 |
20120209121 | Boudier | Aug 2012 | A1 |
20120220865 | Brown et al. | Aug 2012 | A1 |
20120238875 | Savitsky et al. | Sep 2012 | A1 |
20120277576 | Lui | Nov 2012 | A1 |
20130041250 | Pelissier et al. | Feb 2013 | A1 |
20130102889 | Southard et al. | Apr 2013 | A1 |
20130131499 | Chan | May 2013 | A1 |
20130131502 | Blaivas et al. | May 2013 | A1 |
20130150724 | Blaivas et al. | Jun 2013 | A1 |
20130188832 | Ma et al. | Jul 2013 | A1 |
20130218024 | Boctor et al. | Aug 2013 | A1 |
20130324840 | Zhongping et al. | Dec 2013 | A1 |
20140005530 | Liu et al. | Jan 2014 | A1 |
20140031690 | Toji et al. | Jan 2014 | A1 |
20140036091 | Zalev et al. | Feb 2014 | A1 |
20140073976 | Fonte et al. | Mar 2014 | A1 |
20140100440 | Cheline et al. | Apr 2014 | A1 |
20140155737 | Manzke et al. | Jun 2014 | A1 |
20140180098 | Flaherty et al. | Jun 2014 | A1 |
20140188133 | Misener | Jul 2014 | A1 |
20140188440 | Donhowe et al. | Jul 2014 | A1 |
20140276059 | Sheehan | Sep 2014 | A1 |
20140276081 | Tegels | Sep 2014 | A1 |
20140276085 | Miller | Sep 2014 | A1 |
20140276690 | Grace | Sep 2014 | A1 |
20140343431 | Vajinepalli et al. | Nov 2014 | A1 |
20150005738 | Blacker | Jan 2015 | A1 |
20150011887 | Ahn et al. | Jan 2015 | A1 |
20150065916 | Maguire et al. | Mar 2015 | A1 |
20150073279 | Cai et al. | Mar 2015 | A1 |
20150112200 | Oberg et al. | Apr 2015 | A1 |
20150209113 | Burkholz et al. | Jul 2015 | A1 |
20150209526 | Matsubara et al. | Jul 2015 | A1 |
20150294497 | Ng et al. | Oct 2015 | A1 |
20150297097 | Matsubara et al. | Oct 2015 | A1 |
20150327841 | Banjanin et al. | Nov 2015 | A1 |
20150359991 | Dunbar et al. | Dec 2015 | A1 |
20160029995 | Navratil et al. | Feb 2016 | A1 |
20160029998 | Brister et al. | Feb 2016 | A1 |
20160100970 | Brister et al. | Apr 2016 | A1 |
20160101263 | Blumenkranz et al. | Apr 2016 | A1 |
20160113699 | Sverdlik et al. | Apr 2016 | A1 |
20160120607 | Sorotzkin et al. | May 2016 | A1 |
20160143622 | Xie et al. | May 2016 | A1 |
20160166232 | Merritt | Jun 2016 | A1 |
20160202053 | Walker et al. | Jul 2016 | A1 |
20160213398 | Liu | Jul 2016 | A1 |
20160278743 | Kawashima | Sep 2016 | A1 |
20160278869 | Grunwald | Sep 2016 | A1 |
20160296208 | Sethuraman et al. | Oct 2016 | A1 |
20160374644 | Mauldin, Jr. et al. | Dec 2016 | A1 |
20170079548 | Silverstein et al. | Mar 2017 | A1 |
20170086785 | Bjaerum | Mar 2017 | A1 |
20170164923 | Matsumoto | Jun 2017 | A1 |
20170172424 | Eggers | Jun 2017 | A1 |
20170188839 | Tashiro | Jul 2017 | A1 |
20170196535 | Arai et al. | Jul 2017 | A1 |
20170215842 | Ryu et al. | Aug 2017 | A1 |
20170259013 | Boyden et al. | Sep 2017 | A1 |
20170265840 | Bharat | Sep 2017 | A1 |
20170303894 | Scully | Oct 2017 | A1 |
20170367678 | Sirtori et al. | Dec 2017 | A1 |
20180015256 | Southard et al. | Jan 2018 | A1 |
20180116723 | Hettrick et al. | May 2018 | A1 |
20180125450 | Blackbourne et al. | May 2018 | A1 |
20180161502 | Nanan et al. | Jun 2018 | A1 |
20180199914 | Ramachandran et al. | Jul 2018 | A1 |
20180214119 | Mehrmohammadi et al. | Aug 2018 | A1 |
20180225993 | Buras et al. | Aug 2018 | A1 |
20180228465 | Southard et al. | Aug 2018 | A1 |
20180235576 | Brannan | Aug 2018 | A1 |
20180250078 | Shochat et al. | Sep 2018 | A1 |
20180272108 | Padilla et al. | Sep 2018 | A1 |
20180279996 | Cox et al. | Oct 2018 | A1 |
20180286287 | Razzaque | Oct 2018 | A1 |
20180310955 | Lindekugel et al. | Nov 2018 | A1 |
20180317881 | Astigarraga et al. | Nov 2018 | A1 |
20180366035 | Dunbar et al. | Dec 2018 | A1 |
20190060014 | Hazelton et al. | Feb 2019 | A1 |
20190069923 | Wang | Mar 2019 | A1 |
20190076121 | Southard et al. | Mar 2019 | A1 |
20190088019 | Prevrhal et al. | Mar 2019 | A1 |
20190105017 | Hastings | Apr 2019 | A1 |
20190117190 | Djajadiningrat | Apr 2019 | A1 |
20190223757 | Durfee | Jul 2019 | A1 |
20190239850 | Dalvin et al. | Aug 2019 | A1 |
20190282324 | Freeman et al. | Sep 2019 | A1 |
20190298457 | Bharat | Oct 2019 | A1 |
20190307516 | Schotzko et al. | Oct 2019 | A1 |
20190339525 | Yanof et al. | Nov 2019 | A1 |
20190355278 | Sainsbury et al. | Nov 2019 | A1 |
20190365348 | Toume | Dec 2019 | A1 |
20200041261 | Bernstein et al. | Feb 2020 | A1 |
20200069285 | Annangi et al. | Mar 2020 | A1 |
20200113540 | Gijsbers et al. | Apr 2020 | A1 |
20200129136 | Harding et al. | Apr 2020 | A1 |
20200188028 | Feiner et al. | Jun 2020 | A1 |
20200230391 | Burkholz et al. | Jul 2020 | A1 |
20210007710 | Douglas | Jan 2021 | A1 |
20210045716 | Shiran et al. | Feb 2021 | A1 |
20210166583 | Buras | Jun 2021 | A1 |
20210307838 | Xia | Oct 2021 | A1 |
20210353255 | Schneider | Nov 2021 | A1 |
20210402144 | Messerly | Dec 2021 | A1 |
20220022969 | Misener | Jan 2022 | A1 |
20220039685 | Misener et al. | Feb 2022 | A1 |
20220039777 | Durfee | Feb 2022 | A1 |
20220096797 | Prince | Mar 2022 | A1 |
20220104886 | Blanchard et al. | Apr 2022 | A1 |
20220117582 | McLaughlin et al. | Apr 2022 | A1 |
20220160434 | Messerly et al. | May 2022 | A1 |
20220168050 | Sowards et al. | Jun 2022 | A1 |
20220172354 | Misener et al. | Jun 2022 | A1 |
20220211442 | Mclaughlin et al. | Jul 2022 | A1 |
20220381630 | Sowards et al. | Dec 2022 | A1 |
20230113291 | de Wild et al. | Apr 2023 | A1 |
20230240643 | Cermak et al. | Aug 2023 | A1 |
20230389893 | Misener et al. | Dec 2023 | A1 |
20240050061 | McLaughlin et al. | Feb 2024 | A1 |
20240058074 | Misener | Feb 2024 | A1 |
20240062678 | Sowards et al. | Feb 2024 | A1 |
Number | Date | Country |
---|---|---|
2006201646 | Nov 2006 | AU |
114129137 | Sep 2022 | CN |
0933063 | Aug 1999 | EP |
1504713 | Feb 2005 | EP |
1591074 | May 2008 | EP |
3181083 | Jun 2017 | EP |
3530221 | Aug 2019 | EP |
2000271136 | Oct 2000 | JP |
2014150928 | Aug 2014 | JP |
2018175547 | Nov 2018 | JP |
20180070878 | Jun 2018 | KR |
20190013133 | Feb 2019 | KR |
2013059714 | Apr 2013 | WO |
2014115150 | Jul 2014 | WO |
2014174305 | Oct 2014 | WO |
2015017270 | Feb 2015 | WO |
2017096487 | Jun 2017 | WO |
2017214428 | Dec 2017 | WO |
2018026878 | Feb 2018 | WO |
2018134726 | Jul 2018 | WO |
2018206473 | Nov 2018 | WO |
2019232451 | Dec 2019 | WO |
2020002620 | Jan 2020 | WO |
2020016018 | Jan 2020 | WO |
2019232454 | Feb 2020 | WO |
2020044769 | Mar 2020 | WO |
2020102665 | May 2020 | WO |
2020186198 | Sep 2020 | WO |
2022031762 | Feb 2022 | WO |
2022072727 | Apr 2022 | WO |
2022081904 | Apr 2022 | WO |
2022-203713 | Sep 2022 | WO |
WO-2022263763 | Dec 2022 | WO |
2023235435 | Dec 2023 | WO |
2024010940 | Jan 2024 | WO |
2024039608 | Feb 2024 | WO |
2024039719 | Feb 2024 | WO |
Entry |
---|
Stolka, P.J., et al., (2014). Needle Guidance Using Handheld Stereo Vision and Projection for Ultrasound-Based Interventions. In: Galland, P., Hata, N., Barillot, C., Hornegger, J., Howe, R. (eds) Medical Image Computing and Computer-Assisted Intervention—MICCAI 2014. MICCAI 2014. (Year: 2014). |
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Non-Final Office Action dated Jun. 5, 2023. |
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Non-Final Office Action dated Jun. 6, 2023. |
U.S. Appl. No. 17/832,389, filed Jun. 3, 2022 Restriction Requirement dated Jul. 13, 2023. |
U.S. Appl. No. 17/380,767, filed Jul. 20, 2021 Non-Final Office Action dated Mar. 6, 2023. |
U.S. Appl. No. 17/393,283, filed Aug. 3, 2021 Non-Final Office Action dated Mar. 31, 2023. |
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Restriction Requirement dated Feb. 27, 2023. |
PCT/US2021/050973 filed Sep. 17, 2021 International Search Report and Written Opinion dated Nov. 7, 2022. |
U.S. Appl. No. 17/380,767, filed Jul. 20, 2021 Restriction Requirement dated Dec. 15, 2022. |
U.S. Appl. No. 17/393,283, filed Aug. 3, 2021 Restriction Requirement dated Jan. 12, 2023. |
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Non-Final Office Action dated Jan. 23, 2023. |
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Restriction Requirement dated Feb. 1, 2023. |
EZono, eZSimulator, https://www.ezono.com/en/ezsimulator/, last accessed Sep. 13, 2022. |
Sonosim, https://sonosim.com/ultrasound-simulation/? last accessed Sep. 13, 2022. |
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Restriction Requirement dated Aug. 12, 2022. |
Ikhsan Mohammad et al: “Assistive technology for ultrasound-guided central venous catheter placement”, Journal of Medical Ultrasonics, Japan Society of Ultrasonics in Medicine, Tokyo, JP, vol. 45, No. 1, Apr. 19, 2017, pp. 41-57, XPO36387340, ISSN: 1346-4523, DOI: 10.1007/S10396-017-0789-2 [retrieved on Apr. 19, 2017]. |
Lu Zhenyu et al “Recent advances in 5 robot-assisted echography combining perception control and cognition.” Cognitive Computation and Systems The Institution of Engineering and Technology, Michael Faraday House, Six Hills Way, Stevenage Herts. SG1 2AY UK vol. 2 No. 3 Sep. 2, 2020 (Sep. 2, 2020). |
Pagoulatos, N et al. “New spatial localizer based on fiber optics with applications in 3D ultrasound imaging” Proceeding of Spie, vol. 3976 (Apr. 18, 2000; Apr. 18, 2000). |
PCT/US2021/042369 filed Jul. 20, 2021 International Search Report and Written Opinion dated Oct. 25, 2021. |
PCT/US2021/044419 filed Aug. 3, 2021 International Search Report and Written Opinion dated Nov. 19, 2021. |
PCT/US2021/045218 filed Aug. 9, 2021 International Search Report and Written Opinion dated Nov. 23, 2021. |
PCT/US2021/053018 filed Sep. 30, 2021 International Search Report and Written Opinion dated May 3, 2022. |
PCT/US2021/055076 filed Oct. 14, 2021 International Search Report and Written Opinion dated Mar. 25, 2022. |
Sebastian Vogt: “Real-Time Augmented Reality for Image-Guided Interventions”, Oct. 5, 2009, XPO55354720, Retrieved from the Internet: URL: https://opus4.kobv.de/opus4-fau/frontdoor/deliver/index/docld/1235/file/SebastianVogtDissertation.pdf. |
William F Garrett et al: “Real-time incremental visualization of dynamic ultrasound volumes using parallel BSP trees”, Visualization '96. Proceedings, IEEE, NE, Oct. 27, 1996, pp. 235-ff, XPO58399771, ISBN: 978-0-89791-864-0 abstract, figures 1-7, pp. 236-240. |
PCT/US2023/024067 filed May 31, 2023 International Search Report and Written Opinion dated Sep. 15, 2023. |
PCT/US2023/030160 filed Aug. 14, 2023 International Search Report and Written Opinion dated Oct. 23, 2023. |
PCT/US2023/030347 filed Aug. 16, 2023 International Search Report and Written Opinion dated Nov. 6, 2023. |
Practical guide for safe central venous catheterization and management 2017 Journal of Anesthesia vol. 34 published online Nov. 30, 2019 pp. 167-186. |
State, A., et al. (Aug. 1996). Technologies for augmented reality systems: Realizing ultrasound-guided needle biopsies. In Proceedings of the 23rd annual conference on computer graphics and interactive techniques (pp. 439-446) (Year: 1996). |
U.S. Appl. No. 17/380,767, filed Jul. 20, 2021 Notice of Allowance dated Aug. 31, 2023. |
U.S. Appl. No. 17/393,283, filed Aug. 3, 2021 Final Office Action dated Oct. 16, 2023. |
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Advisory Action dated Oct. 5, 2023. |
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Final Office Action dated Aug. 4, 2023. |
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Board Decison dated Oct. 25, 2023. |
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Final Office Action dated Aug. 29, 2023. |
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Final Office Action dated Nov. 21, 2023. |
U.S. Appl. No. 17/832,389, filed Jun. 3, 2022 Non-Final Office Action dated Oct. 6, 2023. |
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Non-Final Office Action dated Mar. 22, 2024. |
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Non-Final Office Action dated Mar. 21, 2024. |
U.S. Appl. No. 17/832,389, filed Jun. 3, 2022 Advisory Action dated Apr. 4, 2024. |
U.S. Appl. No. 17/832,389, filed Jun. 3, 2022 Notice of Allowance dated May 15, 2024. |
U.S. Appl. No. 17/393,283, filed Aug. 3, 2021 Advisory Action dated Jan. 19, 2024. |
U.S. Appl. No. 17/393,283, filed Aug. 3, 2021 Non-Final Office Action dated Feb. 29, 2024. |
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Non-Final Office Action dated Mar. 1, 2024. |
U.S. Appl. No. 17/478,754, filed Sep. 17, 2021 Restriction Requirement dated Jan. 22, 2024. |
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Advisory Action dated Jan. 24, 2024. |
U.S. Appl. No. 17/832,389, filed Jun. 3, 2022 Final Office Action dated Jan. 25, 2024. |
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Notice of Allowance dated Jul. 10, 2024. |
U.S. Appl. No. 17/478,754, filed Sep. 17, 2021 Non-Final Office Action dated Jul. 1, 2024. |
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Notice of Allowance dated Jun. 27, 2024. |
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Final Office Action dated Aug. 5, 2024. |
Number | Date | Country | |
---|---|---|---|
20240008929 A1 | Jan 2024 | US |